Clinical Trial Update: Study Comparing A New Drug Containing The Combination Meloxicam And Cyclobenzaprine In The Treatment Of Acute Lumbago [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a new combination drug containing meloxicam and cyclobenzaprine for acute lumbago has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Cyclobenzaprine (cyclobenzaprine)
• MELOXICAM (MELOXICAM)

Snippet

Sponsor: Eurofarma Laboratorios S.A. | Conditions: Acute Lumbago | Phase 3 | Status: WITHDRAWN